Literature DB >> 25993136

Clinical research in metastatic prostate cancer: a focus on impact and value.

Maha Hussain1, Robert S DiPaola1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25993136     DOI： 10.14694/EdBook_AM.2015.35.17

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN： 1548-8748


× No keyword cloud information.
  2 in total

1.  Modulation in the microRNA repertoire is responsible for the stage-specific effects of Akt suppression on murine neuroendocrine prostate cancer.

Authors:  Abdulrahman Alwhaibi; Fei Gao; Sandeep Artham; Bernard M Hsia; Ashis Mondal; Ravindra Kolhe; Payaningal R Somanath
Journal:  Heliyon       Date:  2018-09-17

2.  Atg7 cooperates with Pten loss to drive prostate cancer tumor growth.

Authors:  Urmila Santanam; Whitney Banach-Petrosky; Cory Abate-Shen; Michael M Shen; Eileen White; Robert S DiPaola
Journal:  Genes Dev       Date:  2016-02-15       Impact factor: 11.361
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.